project id: TCGA-ESCA; case submitter id: TCGA-M9-A5M8; analyte type: DNA; selected normal wgs: true; source center: 23; state: released; a260 a280 ratio: 1.86; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.71; rna integrity number: 7.9; age at index: 58; days to birth: -21433; ethnicity: not reported; gender: male; race: not reported; vital status: Alive; age at diagnosis: 21433; ajcc pathologic m: M0; ajcc pathologic n: N0; ajcc pathologic stage: Stage IIA; ajcc pathologic t: T3; ajcc staging system edition: 7th; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 1007.0; icd 10 code: C15.5; last known disease status: not reported; morphology: 8140/3; primary diagnosis: Adenocarcinoma, NOS; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Lower third of esophagus; synchronous malignancy: No; tissue or organ of origin: Lower third of esophagus; tumor grade: Not Reported; treatment or therapy: no; alcohol history: Yes; cigarettes per day: 2.73972602739726; pack years smoked: 50.0; is ffpe: false; composition: Not Reported; days to sample procurement: 0; initial weight: 300.0; portion submitter id: TCGA-M9-A5M8-01A-11; percent lymphocyte infiltration: 40.0; percent monocyte infiltration: 20.0; percent necrosis: 0.0; percent neutrophil infiltration: 20.0; percent normal cells: 0.0; percent stromal cells: 10.0; percent tumor cells: 90.0; percent tumor nuclei: 90.0;